BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28454228)

  • 1. Prognostic factors of long-term outcome in surgically resectable pancreatic neuroendocrine tumors: A 12-year experience from a single center.
    Zhou B; Duan J; Yan S; Zhou J; Zheng S
    Oncol Lett; 2017 Mar; 13(3):1157-1164. PubMed ID: 28454228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Tumor Markers for Predicting Disease-Free Survival in Surgically Resected Pancreatic Neuroendocrine Tumors.
    Zhou B; Fang B; Yan S; Wang W
    Clin Lab; 2017 Jul; 63(7):1251-1259. PubMed ID: 28792692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Lymph Node Ratio Model for Prognosis of Patients with Pancreatic Neuroendocrine Tumors.
    Osher E; Shalabna E; Klausner JM; Greenman Y; Stern N; Shibolet O; Scapa E; Yakir O; Shor DB; Bar-Yishay I; Shamai S; Sofer Y; Lubezky N; Goykhman Y; Lahat G; Wolf I; Pelles S; Aizic A; Blachar A; Geva R
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of the preoperative main pancreatic duct dilation and neutrophil-to-lymphocyte ratio in pancreatic neuroendocrine tumors (PNETs) of the head after curative resection.
    Zhou B; Zhan C; Xiang J; Ding Y; Yan S
    BMC Endocr Disord; 2019 Nov; 19(1):123. PubMed ID: 31718651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic predictors for recurrence following curative resection in grade I/II pancreatic neuroendocrine tumours.
    Chopde A; Gupta A; Chaudhari V; Parghane R; Basu S; Ostwal V; Ramaswamy A; Puranik A; Shrikhande SV; Bhandare MS
    Langenbecks Arch Surg; 2023 May; 408(1):204. PubMed ID: 37212896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High vimentin expression with E-cadherin expression loss predicts a poor prognosis after resection of grade 1 and 2 pancreatic neuroendocrine tumors.
    Zhou B; Xiang J; Jin M; Zheng X; Li G; Yan S
    BMC Cancer; 2021 Mar; 21(1):334. PubMed ID: 33789624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes and prognostic factors of resected pancreatic neuroendocrine neoplasms: A single-center experience in China.
    Jin K; Luo G; Xu J; Zhang B; Liu C; Ji S; Liu L; Long J; Ni Q; Yu X
    Oncol Lett; 2017 May; 13(5):3163-3168. PubMed ID: 28521422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of different WHO grade 3 pancreatic neuroendocrine neoplasms based on morphology.
    Han X; Xu X; Ma H; Ji Y; Wang D; Kuang T; Wu W; Song B; Li G; Jin G; Lou W
    Endocr Connect; 2018 Feb; 7(2):355-363. PubMed ID: 29472376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study.
    Tong Z; Liu L; Zheng Y; Jiang W; Zhao P; Fang W; Wang W
    World J Surg Oncol; 2017 May; 15(1):108. PubMed ID: 28558772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors.
    Tan QQ; Wang X; Yang L; Chen YH; Tan CL; Zhu XM; Ke NW; Liu XB
    Medicine (Baltimore); 2020 Jun; 99(24):e20324. PubMed ID: 32541455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation.
    Chen J; Yang Y; Liu Y; Kan H
    World J Surg Oncol; 2021 Jan; 19(1):11. PubMed ID: 33436017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological characteristics and prognosis-related factors of resectable pancreatic neuroendocrine tumors: a retrospective study of 104 cases in a single Chinese center.
    Han X; Xu X; Jin D; Wang D; Ji Y; Lou W
    Pancreas; 2014 May; 43(4):526-31. PubMed ID: 24658317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grading Using Ki-67 Index and Mitotic Rate Increases the Prognostic Accuracy of Pancreatic Neuroendocrine Tumors.
    Philips P; Kooby DA; Maithel S; Merchant NB; Weber SM; Winslow ER; Ahmad S; Kim HJ; Scoggins CR; McMasters KM; Martin RCG
    Pancreas; 2018 Mar; 47(3):326-331. PubMed ID: 29351120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role and predictors of lymph node involvement in pancreatic neuroendocrine tumors.
    Ren SJ; Tan QQ; Cao D; Ke NW; Liu XB; Wang X
    Eur J Radiol; 2023 May; 162():110772. PubMed ID: 36940547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value and Clinical Predictors of Lymph Node Metastases in Pancreatic Neuroendocrine Tumors.
    Zhang Z; Liu M; Ji S; Luo G; Xu W; Liu W; Hu Q; Sun Q; Ye Z; Qin Y; Fan G; Yu X; Xu X
    Pancreas; 2020 Mar; 49(3):381-386. PubMed ID: 32132507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors of Lymph Node Metastasis in Patients with Pancreatic Neuroendocrine Tumors (PNETs).
    Wang Z; Cao F; Zhang Y; Fang Y; Li F
    Gastroenterol Res Pract; 2020; 2020():1946156. PubMed ID: 33061957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Factors for Operated Gallbladder Cancer.
    Oven Ustaalioglu BB; Bilici A; Seker M; Kefeli U; Aydin D; Celik S; Demir T; Erkol B
    J Gastrointest Cancer; 2019 Sep; 50(3):451-457. PubMed ID: 29637517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections.
    Boninsegna L; Panzuto F; Partelli S; Capelli P; Delle Fave G; Bettini R; Pederzoli P; Scarpa A; Falconi M
    Eur J Cancer; 2012 Jul; 48(11):1608-15. PubMed ID: 22129889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma?
    Hakeem AR; Marangoni G; Chapman SJ; Young RS; Nair A; Hidalgo EL; Toogood GJ; Wyatt JI; Lodge PA; Prasad KR
    Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):1047-54. PubMed ID: 25051217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-free survival after pancreatectomy for pancreatic neuroendocrine tumours: a 17-year single-center experience of 223 patients.
    Mukkala AN; Ray S; Bevacqua D; McGilvray I; Sapisochin G; Moulton CA; Gallinger S; Cleary SP; Shwaartz C; Wei AC; Reichman T
    J Gastrointest Surg; 2024 Jun; ():. PubMed ID: 38906319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.